| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |